Jakubowski Hieronim
Department of Microbiology & Molecular Genetics, UMDNJ-New Jersey Medical School, International Center for Public Health, Newark 07101-1709, USA.
Clin Chem Lab Med. 2003 Nov;41(11):1462-6. doi: 10.1515/CCLM.2003.224.
Indirect pathways, involving homocysteine (Hcy)-thiolactone and S-nitroso-Hcy, allow incorporation of Hcy into protein. Hcy-thiolactone, synthesized by methionyl-tRNA synthetase in all organisms investigated, including human, modifies proteins post-translationally by forming adducts in which Hcy is linked by amide bonds to epsilon-amino group of protein lysine residues. S-Nitroso-Hcy, synthesized in human vascular endothelial cells, is incorporated translationally into peptide bonds in protein at positions normally occupied by methionine. Hcy-N-hemoglobin and Hcy-N-albumin constitute a major pool of Hcy in human blood. Hcy-thiolactone is present in human plasma. Modification with Hcy-thiolactone leads to protein damage. Hcy-thiolactone is detoxified by Hcy-thiolactonase/paraoxonase present in a subset of high-density lipoprotein particles in humans.
间接途径,涉及同型半胱氨酸(Hcy)-硫内酯和S-亚硝基-Hcy,使得Hcy能够掺入蛋白质中。在包括人类在内的所有被研究生物中,由甲硫氨酰-tRNA合成酶合成的Hcy-硫内酯,通过形成加合物在翻译后修饰蛋白质,其中Hcy通过酰胺键与蛋白质赖氨酸残基的ε-氨基相连。在人类血管内皮细胞中合成的S-亚硝基-Hcy,在翻译过程中掺入到蛋白质中通常由甲硫氨酸占据的肽键位置。Hcy-N-血红蛋白和Hcy-N-白蛋白构成了人类血液中Hcy的主要储存库。Hcy-硫内酯存在于人体血浆中。用Hcy-硫内酯进行修饰会导致蛋白质损伤。Hcy-硫内酯可被人类高密度脂蛋白颗粒亚群中存在的Hcy-硫内酯酶/对氧磷酶解毒。